Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences – Yahoo Finance

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences – Yahoo Finance

CORAL GABLES, Fla., May 17, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate at two upcoming conferences. The management team will also host one-on-one investor meetings at the conferences.

Presentation Details:
Event: H.C. Wainwright Global Investment Conference
Date: May 24, 2022
Time: 4:00 PM Eastern Time
Event: Jefferies Healthcare Conference
Date: June 8, 2022
Time: 11:00 AM Eastern Time
The webcast will be available on the Company’s website, and a replay will be accessible for at least 14 days.
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a commercial stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, best-in-class medicines for rare diseases. Catalyst’s New Drug Application for FIRDAPSE® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada’s national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
For additional information about the Company, please visit
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst’s actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst’s Annual Report on Form 10-K for the fiscal year 2021 and its other filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect Catalyst. Copies of Catalyst’s filings with the SEC are available from the SEC, may be found on Catalyst’s website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.
Source: Catalyst Pharmaceuticals
Investor Relations Contact:
Mary Coleman
Catalyst Pharmaceuticals
(305) 420-3200
Media Contact:

David Schull
Russo Partners
(858) 717-2310

Related Quotes
If a major recession is coming, the financial guru recommends some fast, concrete moves to protect your money.
It’s important to remember that as we watch the stock market crash and our personal net worth take a big hit. While that has certainly happened, it’s important to note that the stock market isn’t the economy.
This trio might be ice cold. But Wall Street says they now have up to 86% upside.
These passive income powerhouses, with yields ranging between 5.5% and 12%, can combat historically high inflation and make patient investors richer over time.
Without investors starting to see a way through challenges and policy markets starting to help, any bear-market rallies aren’t likely to last. This would further damage confidence.
On Friday morning, agricultural equipment giant Deere & Company (NYSE: DE) announced that it just grew its profits about twice as fast as it grew its sales. Reporting its financial results for its fiscal second quarter 2022 Friday, Deere said its net sales and revenue came in at $13.4 billion, up 11% year-over-year. In just the first two hours of trading Friday, Deere stock fell 11.5%.
These innovative and time-tested companies are trading at a discount and begging to be bought by long-term investors.
Tesla (NASDAQ: TSLA) is the undisputed EV leader and trailblazer for the entire sector. The stock rose ahead of the company’s execution, however, keeping many people from owning it from a valuation perspective. There was always the chance of failure, and even CEO Elon Musk said that his company was within about a month of bankruptcy when it was ramping up its Model 3 mass production in 2017.
(Bloomberg) — The world’s richest nation is waking up to an unpleasant and unfamiliar sensation: It’s getting poorer.Most Read from BloombergWalmart’s Troubles Should Have Everyone on High AlertA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsHow an Energy Expert Triggered Vladimir Putin With One WordPutin’s War Means Russia’s Rich Aren’t Welcome at Davos AnymoreOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightAmericans’ collective net worth had
Market rotation out from this defensive sector could signal the start of stock market capitulation based on the analogue comparison of the global financial crisis in 2008.
U.S. stocks are in the midst of their longest selloff in decades. Many investors and analysts looking back at historic pullbacks believe that the current slump that has put the S&P 500 on the cusp of a bear market still has a way to go. The index is down 19% from its Jan. 3 record, flirting with the 20% decline that would end the bull market that began in March 2020.
(Bloomberg) — Inc., stuck with too much warehouse capacity now that the surge in pandemic-era shopping has faded, is looking to sublet at least 10 million square feet of space and could vacate even more by ending leases with landlords, according to people familiar with the situation. Most Read from BloombergWalmart’s Troubles Should Have Everyone on High AlertA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsHow an Energy Expert Triggered Vladimir Putin With One WordPutin’
A bear market for the S&P 500? The stage certainly appears to be set for one, as equity benchmarks added to ugly weekly declines on Friday.
Does the May share price for Pfizer Inc. ( NYSE:PFE ) reflect what it’s really worth? Today, we will estimate the…
The Dow Jones reversed higher while the S&P 500 battled out of bear market territory. Tesla stock dived amid reports about CEO Elon Musk.
The Nasdaq Composite has descended 28% year to date, and the Cboe Volatility Index — commonly referred to as Wall Street’s fear gauge — has soared nearly 80% in the same time frame, highlighting investors’ uneasiness at the present moment. Tesla (NASDAQ: TSLA), one of the most polarizing stocks on Wall Street, has joined the sell-off by shedding 41% of its value since the start of the year. While macro headwinds and Musk’s dramatic potential takeover of Twitter surely haven’t helped Tesla, the EV giant’s business continues to make headway in a grand fashion.
Tech stocks have been one of the worst-performing sectors of the market, losing over 20% of their value so far this year. After a 30-year bull run that saw the Nasdaq 100 index gain nearly 4,000%, the tech-heavy benchmark has turned south and is officially in bear market territory. While that’s made investors leery of dipping their toes into the sector, particularly when energy stocks have gained over 50% in 2022, now just might be a great time to invest in tech stocks.
"People don’t want to admit it, but psychology has the biggest impact on stock prices," investment firm manager George Ball tells Fortune. And investors’ "psychology has turned negative."
In recent months, several investor-favorite stocks have been climbing aboard the good ship stock split, but the news of these splits has taken a back seat to the historic volatility and plummeting stock market. The tech-heavy Nasdaq has fallen deep enough to be well into bear market territory, down roughly 29% from its November high, while the S&P is flirting with the bear as well closing the week down 18.7%. Just last month, Shopify (NYSE: SHOP) announced plans for a 10-for-1 stock split, after years of stellar growth had made the shares inaccessible to many retail investors.
The global business elite will gather for the Wold Economic Forum this week after a two-year hiatus. Wall Street is poised for more market pain is recession fears mount. Investors await a rash of economic data. Fed meeting minutes are set for release.


Leave a Reply

Your email address will not be published.